Hong Kong (HSI) Drug Retail Industry Analysis

Industry Valuation and Performance

Has the Hong Kong Drug Retail Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sat, 26 Apr 2025	HK$214.7b	HK$109.9b	HK$4.1b	58.2x	51.8x	2x
Mon, 24 Mar 2025	HK$213.5b	HK$110.7b	HK$4.2b	62.9x	51.1x	1.9x
Wed, 19 Feb 2025	HK$230.5b	HK$103.8b	HK$3.6b	56.7x	64.1x	2.2x
Fri, 17 Jan 2025	HK$154.8b	HK$103.2b	HK$3.6b	36.9x	43.3x	1.5x
Sun, 15 Dec 2024	HK$166.6b	HK$103.9b	HK$3.6b	39.6x	46.3x	1.6x
Tue, 12 Nov 2024	HK$180.9b	HK$103.5b	HK$3.3b	52.7x	55.1x	1.7x
Thu, 10 Oct 2024	HK$179.8b	HK$105.4b	HK$3.3b	51.5x	53.8x	1.7x
Sat, 07 Sep 2024	HK$137.2b	HK$105.4b	HK$3.3b	37x	41x	1.3x
Mon, 05 Aug 2024	HK$135.9b	HK$103.4b	HK$2.4b	40.7x	56.1x	1.3x
Wed, 03 Jul 2024	HK$135.5b	HK$101.9b	HK$2.4b	40.8x	56.8x	1.3x
Fri, 31 May 2024	HK$163.4b	HK$102.5b	HK$2.4b	48.8x	68.1x	1.6x
Sun, 28 Apr 2024	HK$150.8b	HK$103.7b	HK$2.3b	45.2x	64.8x	1.5x
Tue, 26 Mar 2024	HK$162.4b	HK$103.8b	HK$13.8m	48.5x	11807.2x	1.6x
Thu, 22 Feb 2024	HK$174.4b	HK$105.1b	-HK$1,456,710,874.59	57.6x	-119.7x	1.7x
Sat, 20 Jan 2024	HK$165.0b	HK$106.2b	-HK$1,472,017,604.00	52.5x	-112.1x	1.6x
Mon, 18 Dec 2023	HK$210.6b	HK$106.0b	-HK$1,468,328,668.00	65.8x	-143.4x	2x
Wed, 15 Nov 2023	HK$216.5b	HK$102.0b	-HK$1,739,012,940.00	90.1x	-124.5x	2.1x
Fri, 13 Oct 2023	HK$232.7b	HK$102.4b	-HK$1,676,016,734.00	107.7x	-138.9x	2.3x
Sun, 10 Sep 2023	HK$227.3b	HK$102.0b	-HK$1,669,943,661.00	84.1x	-136.1x	2.2x
Tue, 08 Aug 2023	HK$283.0b	HK$96.0b	-HK$4,166,873,266.00	130.3x	-67.9x	2.9x
Thu, 06 Jul 2023	HK$266.2b	HK$95.5b	-HK$4,144,039,444.00	113.6x	-64.2x	2.8x
Sat, 03 Jun 2023	HK$272.7b	HK$97.8b	-HK$4,327,523,947.00	243.7x	-63x	2.8x
Mon, 01 May 2023	HK$307.2b	HK$95.5b	-HK$4,887,684,955.00	470.3x	-62.9x	3.2x
Wed, 29 Mar 2023	HK$321.9b	HK$91.0b	-HK$1,678,114,888.00	501.9x	-191.8x	3.5x

Current Industry PE

Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 52.2x which is lower than its 3-year average PE of 102x.

The industry is trading close to its 3-year average PS ratio of 2.0x.

Past Earnings Growth

Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 6.5% per year.
This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Hong Kong Drug Retail compare with similar industries?


HK Market	2.19%
Consumer Staples	1.03%
Food and Staples Retail	1.22%
Drug Retail	1.76%
Food Retail	-0.022%
Food Distributors	-1.49%
Big Box Super Stores	-1.89%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
6618 JD Health International	HK$35.80	1.3% +HK$1.4b	34.6%	PE25.9x
241 Alibaba Health Information Technology	HK$4.65	1.8% +HK$1.3b	57.6%	PE58.2x
1833 Ping An Healthcare and Technology	HK$7.10	3.2% +HK$475.5m	-35.7%	PE177.1x
6086 Fangzhou	HK$4.57	4.3% +HK$254.7m	n/a	PS2.1x
314 Sipai Health Technology	HK$4.43	7.5% +HK$234.5m	-28.0%	PS0.7x

Company

Last Price

Valuation

6618 JD Health International

HK$35.80

1.3%
+HK$1.4b

34.6%

PE25.9x

241 Alibaba Health Information Technology

HK$4.65

1.8%
+HK$1.3b

57.6%